[go: up one dir, main page]

NO20015729D0 - Ekspresjonsprodukter av gener involvert i sykdommer relatert til kolesterolmetabolisme - Google Patents

Ekspresjonsprodukter av gener involvert i sykdommer relatert til kolesterolmetabolisme

Info

Publication number
NO20015729D0
NO20015729D0 NO20015729A NO20015729A NO20015729D0 NO 20015729 D0 NO20015729 D0 NO 20015729D0 NO 20015729 A NO20015729 A NO 20015729A NO 20015729 A NO20015729 A NO 20015729A NO 20015729 D0 NO20015729 D0 NO 20015729D0
Authority
NO
Norway
Prior art keywords
genes involved
diseases related
expression products
cholesterol metabolism
cholesterol
Prior art date
Application number
NO20015729A
Other languages
English (en)
Other versions
NO20015729L (no
Inventor
Patrice Denefle
Marie-Francoise Rosier-Montus
Isabelle Arnould-Reguigne
Catherine Prades
Christian Clepet
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9906587A external-priority patent/FR2794131B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20015729D0 publication Critical patent/NO20015729D0/no
Publication of NO20015729L publication Critical patent/NO20015729L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20015729A 1999-05-25 2001-11-23 Ekspresjonsprodukter av gener involvert i sykdommer relatert til kolesterolmetabolisme NO20015729L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9906587A FR2794131B1 (fr) 1999-05-25 1999-05-25 Produits d'expression de genes impliques dans des affections associees au metabolisme du cholesterol
US13945099P 1999-06-16 1999-06-16
PCT/FR2000/001426 WO2000071710A2 (fr) 1999-05-25 2000-05-25 Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol

Publications (2)

Publication Number Publication Date
NO20015729D0 true NO20015729D0 (no) 2001-11-23
NO20015729L NO20015729L (no) 2002-01-22

Family

ID=26234967

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015729A NO20015729L (no) 1999-05-25 2001-11-23 Ekspresjonsprodukter av gener involvert i sykdommer relatert til kolesterolmetabolisme

Country Status (11)

Country Link
EP (1) EP1183350A2 (no)
JP (1) JP2003518918A (no)
KR (1) KR20020033627A (no)
AU (1) AU4931800A (no)
BR (1) BR0010916A (no)
CA (1) CA2371500A1 (no)
HU (1) HUP0203164A2 (no)
IL (1) IL145835A0 (no)
MX (1) MXPA01011882A (no)
NO (1) NO20015729L (no)
WO (1) WO2000071710A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617122B1 (en) 1999-03-15 2003-09-09 Xenon Genetics, Inc. Process for identifying modulators of ABC1 activity
US6656707B2 (en) 2000-08-01 2003-12-02 Amgen Inc. C3b/C4b complement receptor-like molecules and uses thereof
AT413701B (de) * 2001-11-06 2006-05-15 Bmt Medizinische Forschung Und Strukturelle und funktionelle charakterisierung von cdw92
US20100111851A1 (en) 2007-01-05 2010-05-06 The University Of Tokyo Diagnosis and treatment of cancer by using anti-prg-3 antibody
US8680243B2 (en) 2007-11-14 2014-03-25 Chugai Seiyaku Kabushiki Kaisha Diagnosis and treatment of cancer using anti-GPR49 antibody

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941366A2 (en) * 1996-11-06 1999-09-15 Whitehead Institute For Biomedical Research Biallelic markers

Also Published As

Publication number Publication date
KR20020033627A (ko) 2002-05-07
HUP0203164A2 (hu) 2002-12-28
WO2000071710A3 (fr) 2001-05-17
AU4931800A (en) 2000-12-12
IL145835A0 (en) 2002-07-25
MXPA01011882A (es) 2002-05-06
JP2003518918A (ja) 2003-06-17
WO2000071710A2 (fr) 2000-11-30
EP1183350A2 (fr) 2002-03-06
BR0010916A (pt) 2002-02-19
CA2371500A1 (fr) 2000-11-30
NO20015729L (no) 2002-01-22

Similar Documents

Publication Publication Date Title
EP1218013A4 (en) PHOPHOLIPID PRODUCTS OF CELL PROPAGATION INHIBITORS
NO20032271D0 (no) GABA-enhancere i behandlingen av sykdommer relatert til redusert nevrosteroidaktivitet
FI963513A7 (fi) Geenien rinnakkainen ilmentäminen in vivo
NO20016046D0 (no) Administrering av ikke-orale androgene steroider til kvinner
ATE267144T1 (de) Kontinuierliche herstellung von auf kieselsäure- basierenden mikrogelen
NO20055785D0 (no) Kodonoptimaliserte gener for fremstilling av polyumettede fettsyrer i oljesyrerike gjaer
IN1998CH01219A (en) Production of polyunsaturated fatty acid by expression of polyketide-like synthesis genes in plants
AU2001245619A1 (en) Human genes and gene expression products
HUP0200789A3 (en) Regulated expression of genes in plant seeds
NO20011459D0 (no) Gener i biosyntesereaksjonsveien til 1-desoksy-D-xylulose
EP0927270A4 (en) PRESERVATION OF DNA AND RNA BY LYOPHILIZATION OF CULTIVATED HUMAN CELLS
AU2001238511A1 (en) Cosmetics to support skin metabolism
NO20015729D0 (no) Ekspresjonsprodukter av gener involvert i sykdommer relatert til kolesterolmetabolisme
WO2000043929A8 (en) Method and system for buyer-initiated aggregating of buyers to obtain desired products at discounted prices
DK1117676T3 (da) Propanolaminderivater bundet til galdesyrer til behandling af forstyrrelser i lipidstofskiftet
IT1293067B1 (it) Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico
NO20030052D0 (no) Gener og deres genprodukter relevante for mikrosatelitt ustabile (MSI+)tumorer
ZA200109129B (en) Expression products of genes involved in diseases related to cholesterol metabolism.
NO20014540D0 (no) Anvendelse av inulin i kjöttprodukter
NO20011103D0 (no) Lokal avlevering av legemidler til hjertet
AU2003252979A1 (en) Improvements in or relating to the heating of products
NO20003108D0 (no) Anvendelse av melatoninenergiske ligander ved fremstilling av farmasøytiske sammensetninger
DE69828876D1 (de) Zusammensetzung für die behandlung von erkrankungen, die mit apoptose einhergehen
NO20015731D0 (no) Anvendelse av PIT-emulsjoner i fermenteringsprosesser
AU2001287269A1 (en) Human genes and expression products

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application